Medicine and Dentistry
Polycystic Ovary Syndrome
100%
Insulin Resistance
31%
Endometriosis
30%
Messenger RNA
25%
Triacylglycerol
24%
Bisphenol A
23%
Phthalic Acid
21%
Endometrium
19%
Dietary Intake
19%
Fertility Preservation
19%
Body Mass Index
17%
Hyperandrogenism
16%
Haplotype
16%
Glucose Intolerance
14%
Genome Wide Association Study
13%
Metabolic Syndrome
11%
Premenopause
11%
Odds Ratio
11%
Prevalence
11%
Genetic Polymorphism
10%
Breast Cancer
10%
Women's Health
10%
Socioeconomic Status
9%
C Reactive Protein
9%
Adverse Event
9%
Predictive Marker
9%
Gelatinase B
9%
Attitude
9%
Stromal Cell
9%
Interstitial Collagenase
9%
Disease Marker
9%
Fertilization
9%
Hormone Therapy
9%
Middle Age
9%
Early Menopause
9%
Immigrant Woman
9%
Uterine Fibroid
9%
Interleukin 1
9%
Controlled Ovarian Hyperstimulation
9%
Immigrant
9%
Tissue Inhibitor of Metalloproteinase 3
9%
Neck
9%
Distress Syndrome
9%
High Density Lipoprotein Cholesterol
9%
Urokinase
9%
Bone Density
9%
Salpingectomy
9%
Anaphylaxis
9%
Gelatinase A
9%
Cervical Cancer
9%
Biochemistry, Genetics and Molecular Biology
Genetic Polymorphism
38%
Single Nucleotide Polymorphism
30%
Haplotype
26%
Messenger RNA
25%
Bone Density
23%
Genome-Wide Association Study
22%
Triglyceride
20%
Genotyping
20%
Tyrosine Phosphorylation
19%
Catenin
19%
Cadherin
19%
Single-Nucleotide Polymorphism
15%
Insulin Resistance
14%
C-Reactive Protein
11%
Gene Polymorphism
9%
Blood Lipids
9%
SULT1A1
9%
Endometrium
9%
Postmenopause
9%
Cancer Cell
9%
Genetic Risk
9%
Glucose Metabolism
9%
Genetic Association
9%
Angiopoietin-2
9%
Ataxia Telangiectasia Mutated
9%
RANK
9%
MMP2
9%
Gelatinase A
9%
Angiopoietin 1
9%
Urokinase
9%
Urokinase Receptor
9%
Epidermal Growth Factor Receptor
9%
Pleiotrophin
9%
Metalloprotease Inhibitor
9%
Lipid Level
9%
Janus Kinase 1
9%
Hypertriglyceridemia
9%
Plasminogen Activator Inhibitor-1
9%
Stromal Cell
9%
Interleukin-1
9%
Midkine
9%
Polymerase Chain Reaction
9%
Reverse Transcription Polymerase Chain Reaction
9%
Gene Flow
9%
Body Mass
9%
Gene Linkage Disequilibrium
8%
Genetic Divergence
7%
Lipid Storage
7%
Impaired Glucose Tolerance
7%
Insulin Sensitivity
6%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Polycystic Disease
43%
Triacylglycerol
22%
Insulin Resistance
20%
Uterine Cervix Cancer
20%
Catenin
19%
Uvomorulin
19%
Hyperandrogenism
16%
Prevalence
15%
Endometriosis
14%
4,4' Isopropylidenediphenol
14%
Messenger RNA
13%
Phthalic Acid
11%
Premature Ovarian Failure
10%
Gynecologic Disease
10%
Disease Marker
9%
High Density Lipoprotein Cholesterol
9%
Glucose Intolerance
9%
Early Menopause
9%
Muellerian Inhibiting Factor
9%
Interleukin 1
9%
Genetic Risk
9%
Uterine Cervix Carcinoma
9%
Plasminogen Activator Inhibitor 1
9%
Focal Adhesion Kinase
9%
Gonadotropin
9%
Epidermal Growth Factor Receptor
9%
Phytoestrogen
9%
Sulfotransferase
9%
Pleiotrophin
9%
Adenomyosis
9%
Urokinase
9%
Medroxyprogesterone Acetate
9%
Conjugated Estrogen
9%
Ethinylestradiol
9%
Midkine
9%
Comorbidity
9%
Janus Kinase 1
9%
Diethylstilbestrol
5%
Endocrine Disruptor
5%
Receptor
5%
Epidermal Growth Factor
5%
